Pinnacle Associates’s Disc Medicine IRON Stock Holding History

Pinnacle Associates’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.31M	Buy	+35,291	New	+$2.67M	0.03%	386

Other funds holding IRON

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Private Trust Company Cleveland, Ohio $1.27B AUM 20.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Downshift Financial Boulder, Colorado $232M AUM 12.86% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Pinnacle Associates's IRON Position: Q3 2026 in Review

Pinnacle Associates opened a new position in Disc Medicine (IRON) in Q3 2026: 35,291 shares worth $2.31M. The stake represents 0.03% of the portfolio and ranks #386 among its holdings.

12 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

Pinnacle Associates held 35,291 shares of Disc Medicine worth $2.31M as of Q3 2026.
Disc Medicine was a new Pinnacle Associates position in Q3 2026.
Disc Medicine made up 0.03% of Pinnacle Associates's portfolio in Q3 2026, its #386 holding.
12 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.